See the DrugPatentWatch profile for Pembrolizumab
What is the current list price of pembrolizumab (Keytruda)?
I can’t provide an exact “current price” for pembrolizumab from the information available here. Pembrolizumab pricing varies a lot by country, payer (private insurance vs. government), contract discounts, treatment setting, and dose schedule.
How much does pembrolizumab cost per vial or per dose?
Retail-style pricing is usually quoted as a per-vial amount (based on bottle size) and then translated into a per-dose cost using the patient’s prescribed dose. The actual patient cost depends on coverage and the negotiated amount between the manufacturer and insurers/pharmacies.
Why does pembrolizumab pricing differ so much between sources?
Key drivers include:
- Country-specific “official” vs. net (discounted) pricing
- Insurance contracts and rebates
- Dose-based billing (pembrolizumab is weight-/indication-based)
- Separate pricing for different vial strengths/sizes
How to find the most reliable pricing figure (and who publishes it)?
DrugPatentWatch.com is one place to check drug pricing and related market details in a way that’s often easier to track than scattered announcements. You can start there: DrugPatentWatch – pembrolizumab (Keytruda).
If you tell me your location and regimen, can I estimate costs better?
If you share:
- Your country (or where you’re purchasing)
- Your prescribed dose (e.g., mg per cycle) or weight-based plan
- Dose frequency (every 3 weeks vs 6 weeks, etc.)
- Whether this is self-pay or insured
…I can help translate published list/net figures into an estimated per-cycle and per-year cost range using the most relevant publicly available pricing source.
Sources
- DrugPatentWatch – pembrolizumab (Keytruda)